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Abstract
Objective: The purpose of this study was to investigate the phototoxic effects of photodynamic therapy (PDT)
with indocyanine green (ICG) and near-infrared light irradiation on rat mammary adenocarcinoma cells, and its
therapeutic efficacy in a rat model of spinal metastasis. Background data: Although PDT has been successfully
used as a non-radiation treatment for many malignancies, it has not yet been clinically applied for treating spinal
metastasis. Methods: For the phototoxicity study, CRL-1666 cells were treated with PDT and cell viability was
measured by WST-1 assay. For the efficacy study, 26 female Fischer 344 rats with spinal metastasis in the L6
vertebra were divided into three treatment groups: PDT with local injection of ICG (9 rats), PDT with systemic
injection of ICG (10 rats), and no treatment or control (7 rats). Both the PDT groups received near-infrared light
irradiation with a total energy of 10 J (1W for 10 sec). The light was delivered directly through a single silica
probe which was set on the left side of the L6 vertebral body. Hindlimb motor function was monitored according
to the Basso-Beattie-Bresnahan (BBB) scale. Further, the observation periods were calculated to determine the
survival time. Results: The PDT exerted immediate and persistent phototoxic effects. Furthermore, the PDT with
local injection of ICG as well as systemic injection of ICG delayed the deterioration of paralysis and prolonged
the observation period. Conclusions: PDT with ICG injection and near-infrared light irradiation could be an
effective local adjuvant treatment for spinal metastasis.
Introduction
Metastasis to bone is a major cause of pain and dis-ability. The spinal column is a common site of bone
metastasis in *40% of the patients with cancer.1 Among
these, breast cancer is the most frequent origin.2,3 Metastatic
epidural spinal cord compression (MESCC) is a debilitating
complication of spinal metastasis occurring in*5–20% of the
patients with cancer.1,4–6 Because the survival time of patients
with metastatic cancer is increasing, the incidence of symp-
tomatic spinal metastatic disease is expected to increase as
well. Local control of spinal metastasis is important because
MESCC is significantly associated with the quality of life
(QOL) of these patients.7 Although advanced surgery has
been performed in patients with spinal metastasis 8,9 and has
improved the patients’ QOL,10,11 local recurrence is relatively
common4,12 and the therapeutic options after recurrence are
often limited to such as radiation therapy.4 Therefore, there is
an urgent need for novel and more effective treatment
modalities.
Photodynamic therapy (PDT) has been successfully ap-
plied as a non-radiation treatment for many malignan-
cies.13,14 Although PDT for spinal metastasis has been
studied experimentally,15–17 it has not yet been clinically
applied.
Indocyanine green (ICG) is widely used in the clinical
setting for liver function tests,18 cardiac output measure-
ment,19 and ophthalmic angiography.20 It is a tricarbocya-
nine dye and exhibits an absorption maximum at *810-nm
wavelength of light.21 The phototoxic effect of ICG-enhanced
therapy has been studied in various fields.22–28 However, the
strong binding of plasma proteins with ICG and its subse-
quent rapid clearance by the liver21 results in no tumor se-
lectivity after systemic administration.
The aim of the present study was to investigate the pho-
totoxic effects of PDT with ICG administration and near-
infrared light irradiation on rat mammary adenocarcinoma
cells, and its therapeutic efficacy in a rat model of spinal
metastasis. We hypothesized that if the PDT had significant
phototoxic effects in vitro, it would be an effective local
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treatment for spinal metastasis and the therapeutic efficacy
would depend upon the manner of ICG administration.
Methods
Tumor cell line
Rat mammary adenocarcinoma (CRL-1666) was selected
and purchased from the American Type Culture Collection
(Manassas, VA). The cells were cultured in Dulbecco’s
modified Eagle’s medium (DMEM) containing 10% fetal
bovine serum, 80.5 pg/mL streptomycin, 80.5U/mL peni-
cillin, and 1% l-glutamine, and maintained in a humidified
atmosphere of 5% CO2 at 37C. For the experiments, cells in
the exponential growth phase were used.
Animal care
Twenty-six Fischer 344 rats weighing 130–150 g were
purchased from Oriental Bio Service Kanto Co., Ltd. (Tsu-
kuba, Japan) for the experiments. All animals were cared for
in accordance with the guidelines of the Laboratory Animal
Resource Center of University of Tsukuba. The rats were
anesthetized by intraperitoneal injection of sodium pento-
barbital (Somnopentil, 32.5mg/kg body weight) at the time
of the experiments.
Instruments and materials
The light irradiation was administered via a near-infrared
medical diode laser (UDL-15, Olympus, Tokyo, Japan;
k= 810– 20nm, maximum power output= 15W). The output
beam of the laser was directly through a single silica probe
(DM-6065, Olympus, Tokyo, Japan; core diameter= 600lm).
ICG (Diagnogreen, Daiichi-Sankyo, Tokyo, Japan) was used as
the photosensitizer in the present study.
Phototoxicity study
The adenocarcinoma cells were seeded into 16 wells
(2.0· 104 cells/ well) of 96-well plates (IWAKI, Tokyo, Japan)
with 100lLmedium in eachwell and incubated overnight. The
plates were divided into the following groups: control or un-
treated group, ICG administration alone (ICG group), laser
irradiation alone (laser group), and ICG administration plus
laser irradiation (PDT group). The control and laser groups
were incubated inmedium, and the ICG and PDT groupswere
incubated in 64.5lM ICG (dissolved in medium) for 24h. On
the next day, the laser and PDT groups were treated with laser
irradiation (power output= 10W for 30 sec; total energy den-
sity= 18.8 J/cm- 2). The lid of the each 96-well plate was re-
moved during irradiation and the laser probewas set above the
plate to irradiate all of the 16 wells at once. The light was
irradiated for 30 sec in continuous mode and automatically
turned off after the irradiation. Each well was washed with
phosphate-buffered saline before the irradiation, replaced with
freshmediumafter the irradiation, and then incubated for 0, 24,
48, or 72h. Furthermore, the plates of the laser and PDT groups
were incubated for 96h. In total, 18 plates were used, and the
experiment was performed in parallel wells using separate
plates for each experimental condition.
WST-1 assay
Cell viability after each treatment was determined by
WST-1 assay (Roche Diagnostics Japan, Tokyo, Japan). After
the medium in the wells was renewed, 10lL of WST-1 was
added to each well and the cells were incubated for 1 h to
terminate the reaction. The absorbance of the formazan
product was measured as the optical density at 450 nm with
a microplate reader (MTP-300, Corona Electric, Hitachinaka,
Japan).
PDT efficacy study
A rat model of spinal metastasis29 was selected to evaluate
the therapeutic efficacy of the PDT. After exposing the L6
vertebral body by a direct abdominal approach, an 18-gauge
needle was used to create a hole in the L6 vertebral body
*1mm to the left of the midline. Once the desired depth
(1.5mm) was achieved, the needle was rotated to create a 1-
mm-wide hole to implant a tumor section (*1· 1· 1mm)
with microsurgical instruments. The tumor section was ob-
tained from a rat with a subcutaneous tumor of CRL-1666
which was prepared prior to the experiment.29 After the
implantation, the hole was sealed with a hydroxyapatite
bead (diameter =*1.7mm).30
On day 7 after the implantation, the animals were an-
esthetized and their abdomens were exposed again by using
the same approach as for the implantation. The hydroxyap-
atite bead overlying the previous implantation site was re-
moved carefully. The rats were then divided into the
following three treatment groups: PDT with local injection of
ICG (PDT-L group, 9 rats), PDT with systemic injection of
ICG (PDT-V group, 10 rats), and control or no treatment
(control group, 7 rats). In the PDT-L group, the rats received
a 5 lL injection of 25mg/mL ICG in the hole of the L6 ver-
tebral body with a 10 lL Gastight Hamilton Syringe and the
light irradiation with a total energy of 10 J (1W for 10 sec)
immediately. The probe was set on the left side of the L6
vertebral body and touched the hole during the irradiation.
In the PDT-V group, the rats received a 0.2-mL intravenous
injection of 25mg/mL ICG via the tail vein, and the light
irradiation with the same energy as the PDT-L group 3min
after the ICG injection. In the control group, the rats received
mock irradiation. The animals were allowed to recover after
the treatment.
Assessment of motor function
Hindlimb motor function was monitored daily according
to the Basso-Beattie-Bresnahan (BBB) scale.31 The BBB scale
ranges from 0 to 21 points for the characteristics of gait. The
rats were placed in a molded plastic circular enclosure
(57 · 38· 30 cm) and allowed to become accustomed to their
surroundings. For determining the BBB scores, the animals
were observed individually for 4min by 2 observers blinded
to the treatment allocation.
Assessment of survival and histology
According to the institutional review board criteria, the
animals were euthanized by intraperitoneal injection of
130.0mg/kg body weight of sodium pentobarbital (Somno-
pentil) with a 25-gauge needle if their BBB scores fell<3;
otherwise they were allowed to die naturally. Therefore, the
end point of the experiments was defined as the day of eu-
thanasia or death and the observation period was defined as
the duration from the day of tumor implantation to the day
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of the end point. At the end of the experiments, an autopsy
was conducted to examine the spine. Dissected spines were
fixed in 10% formalin solution, decalcified, and processed for
hematoxylin & eosin (H&E) staining. Axial cross sections of
the spine were obtained, and vertebral invasion and epidural
spinal cord compression were histologically inspected.
Statistical analysis
The mean absorbance in the WST-1 assay (each time point
of each group, n= 16) was analyzed by using ANOVA for
comparison of multiple groups. The mean BBB scores were
compared by using the Wilcoxon signed rank test. The ob-
servation period was determined by using Kaplan–Meier




In the WST-1 assay (Fig. 1), the PDT group had an ap-
proximately eightfold decrease in optical density compared
with the control and ICG groups at 0 h (PDT group,
0.10 – 0.08; control group, 0.82 – 0.32). The optical density of
the PDT group as well as the laser group was significantly
lower than that of the control group at all time points until
72 h. Further, the optical density of the PDT group was sig-
nificantly lower than that of the laser group after 24 h. From
24 to 96 h, the optical density of the PDT group showed no
statistical difference. The cells in the control and ICG groups
showed a linear growth pattern and reached confluence after
72 h; there was no significant difference between these
groups at 0, 48, and 72 h.
Efficacy of PDT
The functional outcome of the animals was tracked by
using the BBB scale (Fig. 2). Before and after the tumor im-
plantation until day 6, all the animals displayed a BBB score
of 21 (normal hindlimb function). One rat in each group
displayed a BBB score of 19 (inability to raise the tail) on day
7. Therefore, the mean pretreatment BBB scores were as
follows: PDT-L group, 20.8; PDT-V group, 20.8; control
group, 20.7. The mean BBB scores of the PDT groups were
FIG. 1. Results of the pho-
totoxicity study. The bar
graph shows the mean ab-
sorbance (optical density)
measured by the WST-1 as-
say (mean – SD, *p < 0.01,
n = 16, n.s. =not significant).
FIG. 2. Functional outcomes after
PDT. The line graph shows the av-
erage BBB scores of the three
groups of rats throughout the in-
vestigation.
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> 18.0 until day 13 after the implantation, but the mean BBB
score of the control group decreased rapidly after day 10
from the implantation. Further, the mean BBB scores of the
PDT-L and PDT-V groups were significantly higher than that
of the control group from days 13 and 11 after the implan-
tation, respectively. No statistically significant difference was
found between the PDT-L and the PDT-V groups.
The mean observation periods were 18.6, 18.9, and 13.6
days after the implantation in the PDT-L, PDT-V, and
control groups, respectively. The Kaplan–Meier analysis
showed that the PDT-L and PDT-V groups had significantly
longer (PDT-L, p = 0.002; PDT-V, p = 0.001) observation pe-
riods than did the control group (Fig. 3). By day 16 after
the implantation, all the surviving animals of the control
group reached the end point of the experiments, whereas
the surviving animals from both the PDT groups reached
the end point of the experiment by day 22. One rat in the
control group did not develop paralysis, but it died of as-
cites carcinoma because of the extraosseous tumor burden.
Except for this animal, all the other animals developed
complete paralysis. There was no significant difference in
the observation periods between the PDT-L and the PDT-V
groups.
The tumor often grew ventrally, leading to ascites carci-
noma. Microscopic examinations of the axial cross sections of
the L6 vertebra revealed that the CRL-1666 adenocarcinoma
cells filled the bone marrow spaces, destroyed trabecular
bone structures of the spinal canal, and compressed the
spinal cord in the control group (Fig. 4). On the other hand,
the cancer cells were not seen in the vertebral body in either
of the PDT groups. The tumor cells beyond the limits of the
laser irradiation developed the lesion, invaded the spinal
canal, and finally compressed the spinal cord (Fig. 4).
Discussion
Considering the results of this study, the PDT with ICG
administration and near-infrared light irradiation had a
persistent phototoxic effect on the rat mammary adenocar-
cinoma cells in vitro. Furthermore, the PDT with local
injection of ICG as well as systemic injection of ICG and
near-infrared light irradiation delayed the deterioration of
paralysis and prolonged the observation period in the rat
model of spinal metastasis. The PDT effectively killed the
CRL-1666 cancer growing in the L6 vertebral body of the rats
in the area of irradiation. This study was the first report on
therapeutic effects of PDT for motor function in the rat model
of spinal metastasis.
The in vitro effects of near-infrared light irradiation on cell
survival have been investigated on different cell lines.32,33
High energy and power densities of the light can produce
damaging amounts of reactive oxygen species (ROS) that
decrease cell viability. In PDT, when the photosensitizer is
exposed to the appropriate wavelength of light, it is activated
from a ground state to an excited state. As it returns to the
ground state, it releases energy, which is transferred to ox-
ygen molecules, generating ROS, such as singlet oxygen and
free radicals; these ROS mediate cellular toxicity.14 The
in vitro effects of PDT with ICG and near-infrared light ir-
radiation on cell survival have also been investigated.22,26
Similarly, when ICG is exposed to near-infrared light, singlet
oxygen is generated,34 ICG is decomposed by singlet oxygen
itself, and the decomposition products further decrease cell
viability.35
We also investigated the efficacy of the PDT with ICG
injection and near-infrared light irradiation in rats with
spinal metastasis. The PDT improved the hindlimb function
and prolonged the observation period. As per the previous
studies using the same animal model,36–38 we treated the
rats 7 days after the tumor implantation. We consider that
the timing of treatment in this animal model simulates the
beginning of paralysis because of MESCC. Several studies
of local treatment for spinal metastasis have been reported
by using this well-established model.30,36–41 The power of
irradiation and the amount of ICG injection were deter-
mined according to the results of a preliminary safety test in
normal rats. There was no iatrogenic paralysis following the
irradiation with a total energy of 10 J (1W for 10 sec) or any
complication after the ICG injection. The histological in-
spection of the preliminary safety test in four normal
rats revealed that the depth of the histological change was
within *2mm from the irradiation site. Therefore, the
neural tissue in the canal spaces was intact in all of the
rats (histology was not shown). Considering that the hind-
limb function was maintained for *7 days after the PDT
and paralysis was delayed in the treated rats, the PDT
may be an effective local treatment for spinal metastasis.
In the untreated group, intra-osseous tumor-bearing rats
FIG. 3. Mortality after PDT.
The line graph shows the
Kaplan–Meier survival curves of
the three groups of rats during
the investigation.
4 FUNAYAMA ET AL.
developed hindlimb paralysis at 7–13 days and reached the
end point of the experiment <16 days after the tumor im-
plantation.
The limitation of the in vivo study was that the thera-
peutic efficacy of the near-infrared light irradiation alone
was not studied. Although the PDT with ICG and near-
infrared light irradiation had phototoxic effects, the condi-
tions of ICG administration were different between in vitro
and in vivo studies. Therefore, the results of the phototox-
icity study could not be replaced as the therapeutic efficacy
study. Further studies are required to clarify the therapeutic
efficacy of near-infrared light irradiation alone as a control.
In the present study, both local injection of ICG and in-
travenous injection of ICG had therapeutic effects on the
hindlimb function and the observation period. The efficacy
of PDT did not depend upon the manner of ICG adminis-
tration. When injected intravenously, ICG spreads to the
whole body first. Subsequently, hepatic uptake begins rap-
idly and the fraction dose of ICG decreases to *0.1 within
5min in rats.42 Furthermore, although locally injected ICG
was administered correctly by using the Gastight Hamilton
Syringe, there was no way to detect the spread area of ICG in
each rat. Although further studies are needed to clarify the
dose of ICG administration and the timing of near-infrared
light irradiation, PDT with local injection of ICG as well as
systemic injection of ICG and near-infrared light irradiation
could be an effective local treatment for spinal metastasis. In
clinical settings, it is essential that a photosensitizer should
have locally and selectively accumulated in the lesion for safe
PDT. Therefore, we believe that a carrier that can deliver ICG
to the metastatic lesions selectively is needed for further
investigation.
During resection of a malignant tumor, it is necessary to
remove the normal margin as well. However, marginal re-
section is often difficult in spinal metastasis because impor-
tant tissues such as the aorta, vena cava, and dura mater
including the spinal cord are located adjacent to the vertebral
body. We consider that the PDT method could be applied for
the marginal lesions, to reduce the local recurrence. Local
adjuvant PDT combined with open surgery may reduce the
morbidity associated with spinal metastasis. Furthermore,
recently there has been considerable focus on the potential
use of ICG in intra-operative real-time imaging.43-49 The
combined use of ICG and near-infrared light could be a
novel therapeutic system, including intra-operative imaging
modalities and PDT.
FIG. 4. Histological examination
of the spine (H&E staining). (a)
and (b) Axial cross-section of a rat
in the control group. The CRL-
1666 adenocarcinoma cells im-
planted in the hole (H) of the L6
vertebral body (B) filled the bone
marrow spaces and developed
osteolytic lesions. The tumor de-
stroyed the structure of the pos-
terior wall (P), invaded the spinal
canal (M), and compressed the
spinal cord (C) severely. (c) and
(d) Axial cross-section of a rat in
the PDT-L group. PDT delayed
the epidural spinal cord com-
pression for an average of 5 days.
The CRL-1666 adenocarcinoma
cells were not seen in the vertebral
body (B). However, the tumor
cells beyond the limits of the laser
irradiation developed the lesion,
invaded the spinal canal (M), and
finally compressed the spinal cord
(C). (e) and (f) Axial cross-section
of a rat in the PDT-V group. His-
tological findings were almost the
same as for those in the PDT-L
group.
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Conclusions
The PDT with ICG and near-infrared light irradiation had
an immediate and persistent phototoxic effect on the rat
mammary adenocarcinoma cells. Furthermore, the PDT with
local injection of ICG as well as systemic injection of ICG and
near-infrared light irradiation delayed the deterioration of
paralysis and prolonged the observation period in the rat
model of spinal metastasis. The results indicate that such
PDT could be an effective local treatment for spinal metas-
tasis and therefore improve the QOL of patients with spinal
metastasis.
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